Characterizing Complex Glycosylated Biotherapeutics
Driving R&D Innovation through Partnerships
Automating MS-Based Analytics of Novel Therapeutic Oligos
Sartorius Accelerates Development Processes by a Factor of 3
Fully Automated HT HCP Analysis of Highly Diverse Samples
Immatics Digitalizes CGT Discovery with Genedata Biologics
Automating QC of Therapeutic Oligonucleotides
Pfizer Builds on the Genedata Biopharma E2E Workflow Platform
N-Glycosylation Monitoring of Biopharmaceuticals
MorphoSys Accelerates Antibody R&D with Genedata Biologics
Assessing Developability of Novel Biotherapeutics
MAM Validation in Biopharma Process Characterization
Streamlining MS-based Analysis of Novel Biotherapeutics
Secure Data Is FAIR(er) Data
Data-Driven Decisions to Accelerate Biopharma R&D
MorphoSys Digitalizes Large-Molecule R&D
Kymab Automates Lab Operations with Genedata
Janssen, Celgene, and Aptevo Streamline Discovery Operations
A Single Source of Truth for Biopharma Discovery Data
A Discovery Platform that Automates Daily Work
Harmonizing & Standardizing Discovery Operations
A Proven Data Backbone for Biopharma Operations
A Constantly Evolving Discovery Platform
A Central Data Infrastructure for Decision-Making
Enabling In-depth MS-based Characterization of Biopharmaceuticals
Implementing MAM for Biotherapeutic Characterization
Automated Data Processing for a Novel MS-Based HTS Platform
Immuno-Oncology Case Study
Translational Research: Heightened Patient Privacy Concerns
The Bioinformatics Challenge of 2 Million Genomes
Efficient Genomic Profiling of Patients
